---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-24-002134"
form_type: "8-K"
ticker: "TENX"
cik: "0000034956"
company_name: "TENAX THERAPEUTICS, INC."
filed_at: "2024-02-23T23:59:59+00:00"
generated_at: "2026-06-05T17:44:04.501733+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Tenax Therapeutics regains Nasdaq minimum float compliance; deficiency closed

## Summary
- Received Nasdaq notice on Feb 22, 2024 confirming over 500,000 publicly held shares.
- Regained compliance with Nasdaq Listing Rule 5550(a)(4) regarding minimum public float.
- Prior deficiency notice on Jan 11, 2024 has been resolved and matter closed.
- Company remains listed on Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001654954-24-002134
- form_type: 8-K
- ticker: TENX
- cik: 0000034956
- company_name: TENAX THERAPEUTICS, INC.
- filed_at: 2024-02-23T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/34956/000165495424002134/0001654954-24-002134-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/34956/000165495424002134/tenx_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-24-002134
- JSON: https://secwatch.observer/filing/0001654954-24-002134.json
- Plain text: https://secwatch.observer/filing/0001654954-24-002134.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.